These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14990331)

  • 1. QT and JT dispersion in the drug-induced long QT syndrome in anaesthetized rabbits is accurately detected by a three-lead surface ECG measurement.
    Lu HR; Van Ammel K; Vlaminckx E; De Clerck F
    J Pharmacol Toxicol Methods; 2004; 49(2):71-9. PubMed ID: 14990331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model.
    Lu HR; Remeysen P; Somers K; Saels A; De Clerck F
    J Cardiovasc Electrophysiol; 2001 May; 12(5):538-45. PubMed ID: 11386514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
    Lu HR; Remeysen P; De Clerck F
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventricular dispersion in repolarization causes bifid T waves in dogs with dofetilide-induced long QT syndrome.
    Meijborg VM; Chauveau S; Janse MJ; Anyukhovsky EP; Danilo PR; Rosen MR; Opthof T; Coronel R
    Heart Rhythm; 2015 Jun; 12(6):1343-51. PubMed ID: 25724833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
    Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.
    Carlsson L; Andersson B; Linhardt G; Löfberg L
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):82-9. PubMed ID: 19528812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.
    Lande G; Maison-Blanche P; Fayn J; Ghadanfar M; Coumel P; Funck-Brentano C
    Clin Pharmacol Ther; 1998 Sep; 64(3):312-21. PubMed ID: 9757155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT and JT dispersion in patients with monomorphic or polymorphic ventricular tachycardia/ventricular fibrillation.
    Shimizu H; Ohnishi Y; Inoue T; Yokoyama M
    J Electrocardiol; 2001 Apr; 34(2):119-25. PubMed ID: 11320459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.
    Huang ZJ; Dai DZ; Li N; Na T; Ji M; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):310-7. PubMed ID: 17324143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of drug-induced QT interval prolongation in conscious rabbits.
    Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
    J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs.
    van der Linde H; Van de Water A; Loots W; Van Deuren B; Lu HR; Van Ammel K; Peeters M; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):168-77. PubMed ID: 15935709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sodium in contrast medium-induced polymorphic ventricular tachycardia: results in a rabbit model of lengthened QT interval.
    Idée JM; Bourgoin-Balut C; Lefevre T; Zamia P; Goulas V; Gaillard S; Mathias C; Bonnemain B
    Acad Radiol; 1998 Jun; 5(6):435-43. PubMed ID: 9615154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT and JT dispersion in children with long QT syndrome.
    Shah MJ; Wieand TS; Rhodes LA; Berul CI; Vetter VL
    J Cardiovasc Electrophysiol; 1997 Jun; 8(6):642-8. PubMed ID: 9209965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Late Sodium Current Contributes to the Electrophysiological Effects of Chronic, but Not Acute, Dofetilide Administration.
    Qiu XS; Chauveau S; Anyukhovsky EP; Rahim T; Jiang YP; Harleton E; Feinmark SJ; Lin RZ; Coronel R; Janse MJ; Opthof T; Rosen TS; Cohen IS; Rosen MR
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003655. PubMed ID: 27071826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.
    Boriani G; Biffi M; De Simone N; Bacchi L; Martignani C; Bitonti F; Zannoli R; Butrous G; Branzi A
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1935-8. PubMed ID: 11139961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
    De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
    Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.